Ultimovacs ASA (ULTI.OL)

NOK 2.05

(0.0%)

Long Term Debt Summary of Ultimovacs ASA

Ultimovacs ASA's latest annual long term debt in 2023 was 1.88 Million NOK , down -49.21% from previous year.
Ultimovacs ASA's latest quarterly long term debt in 2024 Q2 was 1.17 Million NOK , down 0.0% from previous quarter.
Ultimovacs ASA reported annual long term debt of 3.71 Million NOK in 2022, up 712.47% from previous year.
Ultimovacs ASA reported annual long term debt of 457 Thousand NOK in 2021, down -77.98% from previous year.
Ultimovacs ASA reported quarterly long term debt of 1.64 Million NOK for 2024 Q1, down 0.0% from previous quarter.
Ultimovacs ASA reported quarterly long term debt of 2.29 Million NOK for 2023 Q3, down -16.87% from previous quarter.

Annual Long Term Debt Chart of Ultimovacs ASA (2023 - 2015)

Historical Annual Long Term Debt of Ultimovacs ASA (2023 - 2015)

Year	Long Term Debt	Long Term Debt Growth
2023	1.88 Million NOK	-49.21%
2022	3.71 Million NOK	712.47%
2021	457 Thousand NOK	-77.98%
2020	2.07 Million NOK	-9.82%
2019	2.3 Million NOK	0.0%
2018	- NOK	0.0%
2017	- NOK	0.0%
2016	- NOK	0.0%
2015	- NOK	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	1.17 Million NOK	0.0%
2024 Q1	1.64 Million NOK	0.0%
2023 Q3	2.29 Million NOK	-16.87%
2023 FY	1.88 Million NOK	-49.21%
2023 Q2	2.76 Million NOK	-13.68%
2023 Q4	1.88 Million NOK	-17.89%
2023 Q1	3.2 Million NOK	-13.79%
2022 Q3	935 Thousand NOK	30.95%
2022 Q2	714 Thousand NOK	82.61%
2022 FY	3.71 Million NOK	712.47%
2022 Q1	391 Thousand NOK	-14.44%
2022 Q4	3.71 Million NOK	297.11%
2021 Q2	1.28 Million NOK	-23.9%
2021 FY	457 Thousand NOK	-77.98%
2021 Q1	1.68 Million NOK	-18.75%
2021 Q4	457 Thousand NOK	-47.65%
2021 Q3	873 Thousand NOK	-31.96%
2020 Q4	2.07 Million NOK	-1.19%
2020 Q3	2.1 Million NOK	43.25%
2020 Q2	1.46 Million NOK	-39.07%
2020 FY	2.07 Million NOK	-9.82%
2020 Q1	2.4 Million NOK	4.56%
2019 Q2	3.67 Million NOK	0.0%
2019 Q4	2.3 Million NOK	-32.99%
2019 FY	2.3 Million NOK	0.0%
2019 Q3	3.43 Million NOK	-6.46%
2018 Q3	- NOK	0.0%
2018 Q1	- NOK	0.0%
2018 FY	- NOK	0.0%
2018 Q2	- NOK	0.0%
2018 Q4	- NOK	0.0%
2017 FY	- NOK	0.0%
2017 Q4	- NOK	0.0%
2016 FY	- NOK	0.0%
2015 FY	- NOK	0.0%

Peer Long Term Debt Comparison of Ultimovacs ASA

Name	Long Term Debt	Long Term Debt Difference
Arctic Bioscience AS	2.04 Million NOK	7.943%
Aqua Bio Technology ASA	- NOK	-Infinity%
ArcticZymes Technologies ASA	8.41 Million NOK	77.585%
BerGenBio ASA	- NOK	-Infinity%
Hofseth BioCare ASA	97.1 Million NOK	98.058%
PCI Biotech Holding ASA	- NOK	-Infinity%
Thor Medical ASA	- NOK	-Infinity%